# FDA Inspection 1062807 - GeneXtend, LLC - August 17, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/genextend-llc/ddaed345-a1ec-4042-93bf-ad693ec786ec
Source feed: FDA_Inspections

> FDA Inspection 1062807 for GeneXtend, LLC on August 17, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1062807
- Company Name: GeneXtend, LLC
- Inspection Date: 2018-08-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1217689 - 2023-09-13](https://www.globalkeysolutions.net/records/fda_inspections/genextend-llc/73998613-91c5-4132-a110-84df3288d026)
- [FDA Inspection 1217689 - 2023-09-13](https://www.globalkeysolutions.net/records/fda_inspections/genextend-llc/582dd0cf-f56d-49a3-a5f6-111ee6b59576)
- [FDA Inspection 1062807 - 2018-08-17](https://www.globalkeysolutions.net/records/fda_inspections/genextend-llc/c3940175-50d5-4b4b-8bc1-62320e437118)

Company: https://www.globalkeysolutions.net/companies/genextend-llc/efa8624c-2ecb-4d56-804e-f40847f55404

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d